Monday, 8 April 2013

Kadcyla new breast cancer drug

Dear all hands
Recent days, FDA  approved new drug for breast cancer, this breast cancer drug has  generic name kadcyla. Kadcyla working when  a breast cancer patient in the phase of metatesis. So its must be combined with another curing methode such of chemoterapy. Kadcyla , based on clinical experience capable to improve live quality of breast cancer patient. Because kadcyla is very selective drug and only targeting cancer cell, so kadcyla has minor side effect.

No comments:

Post a Comment